Gene expression profiling of alveolar soft-part sarcoma (ASPS)
Open Access
- 15 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 9 (1), 22
- https://doi.org/10.1186/1471-2407-9-22
Abstract
Background Alveolar soft-part sarcoma (ASPS) is an extremely rare, highly vascular soft tissue sarcoma affecting predominantly adolescents and young adults. In an attempt to gain insight into the pathobiology of this enigmatic tumor, we performed the first genome-wide gene expression profiling study. Methods For seven patients with confirmed primary or metastatic ASPS, RNA samples were isolated immediately following surgery, reverse transcribed to cDNA and each sample hybridized to duplicate high-density human U133 plus 2.0 microarrays. Array data was then analyzed relative to arrays hybridized to universal RNA to generate an unbiased transcriptome. Subsequent gene ontology analysis was used to identify transcripts with therapeutic or diagnostic potential. A subset of the most interesting genes was then validated using quantitative RT-PCR and immunohistochemistry. Results Analysis of patient array data versus universal RNA identified elevated expression of transcripts related to angiogenesis (ANGPTL2, HIF-1 alpha, MDK, c-MET, VEGF, TIMP-2), cell proliferation (PRL, IGFBP1, NTSR2, PCSK1), metastasis (ADAM9, ECM1, POSTN) and steroid biosynthesis (CYP17A1 and STS). A number of muscle-restricted transcripts (ITGB1BP3/MIBP, MYF5, MYF6 and TRIM63) were also identified, strengthening the case for a muscle cell progenitor as the origin of disease. Transcript differentials were validated using real-time PCR and subsequent immunohistochemical analysis confirmed protein expression for several of the most interesting changes (MDK, c-MET, VEGF, POSTN, CYP17A1, ITGB1BP3/MIBP and TRIM63). Conclusion Results from this first comprehensive study of ASPS gene expression identifies several targets involved in angiogenesis, metastasis and myogenic differentiation. These efforts represent the first step towards defining the cellular origin, pathogenesis and effective treatment strategies for this atypical malignancy.Keywords
This publication has 61 references indexed in Scilit:
- ADAMs in cancer cell proliferation and progressionCancer Science, 2007
- Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcomaThe Lancet Oncology, 2006
- Alveolar soft-part sarcoma: a review and updateJournal of Clinical Pathology, 2006
- Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adultsJournal of Pediatric Surgery, 2006
- Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodiesCarcinogenesis: Integrative Cancer Research, 2005
- The muscle integrin binding protein (MIBP) interacts with α7β1 integrin and regulates cell adhesion and laminin matrix depositionDevelopmental Biology, 2003
- Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways?Current Opinion in Clinical Nutrition and Metabolic Care, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- A Novel Human Striated Muscle RING Zinc Finger Protein, SMRZ, Interacts with SMT3b via Its RING DomainPublished by Elsevier BV ,2001
- MDC-9 (ADAM-9/Meltrin γ) Functions as an Adhesion Molecule by Binding the αvβ5 IntegrinBiochemical and Biophysical Research Communications, 2001